IPP Bureau
GlaxoSmithKline Pharmaceuticals appoints GoApptiv as super stockist
By IPP Bureau - June 25, 2024
This tie-up will have no impact on any other brands of the company
Venus Remedies clinches WHO-backed PAHO tender
By IPP Bureau - June 25, 2024
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs
Sun Pharma’s Utreglutide demonstrates significant weight loss at the American Diabetes Association 84th Scientific Sessions
By IPP Bureau - June 25, 2024
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
Sun Pharma completes Taro merger
By IPP Bureau - June 25, 2024
Combined entity is better positioned to compete in increasingly competitive generics industry
Arkema grants technology license to Seqens to manufacture PEKK for sale in medical implantable applications
By IPP Bureau - June 25, 2024
PEKK is a high-performance polymer family used in aerospace and other demanding markets
Ascentage Pharma closes US$ 75 million equity investment by Takeda
By IPP Bureau - June 24, 2024
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
MediPharm Labs acquires advanced medical cannabis delivery method technology from Remidose Aerosols
By IPP Bureau - June 24, 2024
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
EMA approves Biocon Biologics’ new mAbs facility in India
By IPP Bureau - June 24, 2024
Renews GMP certifications for India and Malaysia sites
CCRAS to organize national consultative meet on ‘Research Priority Settings in Traditional Medicine’ in collaboration with WHO
By IPP Bureau - June 24, 2024
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
.jpg "Cipla gets 6 observations from USFDA for Goa facility")
Cipla gets 6 observations from USFDA for Goa facility
By IPP Bureau - June 24, 2024
The company will work closely with the USFDA and is committed to address these comprehensively within stipulated time
Ami Organics raises Rs. 400 crores through QIP
By IPP Bureau - June 24, 2024
The Issue opened on June 18, 2024 and closed on June 21, 2024
AstraZeneca Pharma India updates on exploring contract manufacturer
By IPP Bureau - June 24, 2024
The company will now explore a buyer for its manufacturing site and exit in due course
Truqap plus Faslodex approved in the EU for patients with advanced ER-positive breast cancer
By IPP Bureau - June 22, 2024
Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in a biomarker-altered population
AbbVie appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors
By IPP Bureau - June 22, 2024
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Bristol Myers Squibb receives USFDA accelerated approval of Krazati in combination with Cetuximab for CRC
By IPP Bureau - June 22, 2024
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
